- Home
- MTEN vs MIST Comparison
MTEN vs MIST Comparison
Compare MTEN & MIST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MTEN
- MIST
- Stock Information
- Founded
- MTEN 2015
- MIST 2003
- Country
- MTEN China
- MIST Canada
- Employees
- MTEN N/A
- MIST N/A
- Industry
- MTEN Building Products
- MIST Biotechnology: Pharmaceutical Preparations
- Sector
- MTEN Industrials
- MIST Health Care
- Exchange
- MTEN Nasdaq
- MIST Nasdaq
- Market Cap
- MTEN 97.9M
- MIST 89.8M
- IPO Year
- MTEN 2024
- MIST N/A
- Fundamental
- Price
- MTEN $12.02
- MIST $1.71
- Analyst Decision
- MTEN
- MIST Strong Buy
- Analyst Count
- MTEN 0
- MIST 2
- Target Price
- MTEN N/A
- MIST $7.50
- AVG Volume (30 Days)
- MTEN 37.3K
- MIST 658.4K
- Earning Date
- MTEN 04-30-2025
- MIST 08-07-2025
- Dividend Yield
- MTEN N/A
- MIST N/A
- EPS Growth
- MTEN N/A
- MIST N/A
- EPS
- MTEN N/A
- MIST N/A
- Revenue
- MTEN $10,120,257.00
- MIST N/A
- Revenue This Year
- MTEN N/A
- MIST N/A
- Revenue Next Year
- MTEN N/A
- MIST N/A
- P/E Ratio
- MTEN N/A
- MIST N/A
- Revenue Growth
- MTEN 23.03
- MIST N/A
- 52 Week Low
- MTEN $1.81
- MIST $0.63
- 52 Week High
- MTEN $16.60
- MIST $2.75
- Technical
- Relative Strength Index (RSI)
- MTEN N/A
- MIST 60.15
- Support Level
- MTEN N/A
- MIST $1.67
- Resistance Level
- MTEN N/A
- MIST $1.80
- Average True Range (ATR)
- MTEN 0.00
- MIST 0.08
- MACD
- MTEN 0.00
- MIST -0.01
- Stochastic Oscillator
- MTEN 0.00
- MIST 43.24
About MTEN Mingteng International Corporation Inc. Ordinary Shares
Mingteng International Corp Inc operates as an automotive mold developer and supplier in China. It provides a wide range of products including casting molds for turbocharger systems, braking systems, steering and differential systems, and other automotive system parts. Besides, it also produces molds for new energy electric vehicle motor drive systems, battery pack systems, and engineering hydraulic components, which are widely used in automobile, construction machinery, and other manufacturing industries.
About MIST Milestone Pharmaceuticals Inc.
Milestone Pharmaceuticals Inc is a biopharmaceutical company dedicated to developing and commercializing etripamil for the treatment of cardiovascular medicines. Etripamil is a calcium channel blocker developed as a rapid-onset nasal spray to be administered by the patient to treat episodes of paroxysmal supraventricular tachycardia, or PSVT. The company has an ongoing Phase 2 clinical trial for patients with atrial fibrillation experiencing a rapid ventricular rate (AFib-RVR).